Silver Book Fact

A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.

Lunn, Michael PT, Richard AC Hughes, and Philip J Wiffen. Duloxetine for Treating Painful Neuropathy or Chronic Pain. Cochrane Database of Systematic Reviews. 2009; 4. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007115.pub2/abstract

Reference

Title
Duloxetine for Treating Painful Neuropathy or Chronic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2009
Authors
Lunn, Michael PT, Richard AC Hughes, and Philip J Wiffen
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning…  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • Topical NSAIDs were found in a meta-analysis to be significantly more effective than placebo in reducing persistent pain from musculoskeletal conditions.  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.